• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促进多州药房实践:简化继续教育要求。

Facilitating multistate pharmacy practice: Streamlining continuing pharmacy education requirements.

出版信息

J Am Pharm Assoc (2003). 2023 May-Jun;63(3):731-735. doi: 10.1016/j.japh.2023.02.013. Epub 2023 Feb 14.

DOI:10.1016/j.japh.2023.02.013
PMID:36894433
Abstract

A major regulatory impediment to achieving multistate pharmacist licensure is state-specific Continuing Pharmacy Education (CPE) mandates. States vary on CPE requirements in 6 key domains, presenting a potentially significant administrative burden for multistate pharmacists. In the short term, replicating the nursing compact model of CPE regulation is the most viable model for the pharmacy profession. In this model, a pharmacist would have to follow just the CPE requirements for the state where the pharmacist maintains primary residence, and maintenance of this home state license would be automatically recognized by other states in which the pharmacist practices.

摘要

实现多州药剂师执照的主要监管障碍是各州特定的继续教育(CPE)要求。各州在 6 个关键领域的 CPE 要求各不相同,这给多州药剂师带来了潜在的重大行政负担。短期内,复制护理契约模式的 CPE 监管是该行业最可行的模式。在这种模式下,药剂师只需遵守其主要居住州的 CPE 要求,并且其居住州的执照维持情况将自动被其执业的其他州所认可。

相似文献

1
Facilitating multistate pharmacy practice: Streamlining continuing pharmacy education requirements.促进多州药房实践:简化继续教育要求。
J Am Pharm Assoc (2003). 2023 May-Jun;63(3):731-735. doi: 10.1016/j.japh.2023.02.013. Epub 2023 Feb 14.
2
Toward Multistate Pharmacy Practice: Enhancing Mobility and Portability of Pharmacist Licensure.迈向多州药学实践:增强药师执照的流动性和可移植性。
Ann Pharmacother. 2021 Mar;55(3):409-412. doi: 10.1177/1060028020945254. Epub 2020 Jul 30.
3
The Basis for Elimination of the Jurisprudence Examination as a Condition of Pharmacist Licensure in Idaho.消除爱达荷州药剂师执照授予条件中司法考试的基础。
Am J Pharm Educ. 2023 Oct;87(10):100119. doi: 10.1016/j.ajpe.2023.100119. Epub 2023 May 19.
4
A scoping review of continuing education models and statutory requirements for pharmacists globally.全球药师继续教育模式和法定要求的范围综述。
BMC Med Educ. 2024 Mar 27;24(1):343. doi: 10.1186/s12909-024-05322-4.
5
Quantitative and qualitative survey feedback of pharmacists regarding current and prospective licensure models.药师对当前和未来许可模式的定量和定性调查反馈。
J Am Pharm Assoc (2003). 2024 May-Jun;64(3):102031. doi: 10.1016/j.japh.2024.02.004. Epub 2024 Feb 8.
6
[Clinical Training of Pharmacists after Licensure and Career Paths in Medical Institutions].[药师执业后的临床培训及医疗机构职业发展路径]
Yakugaku Zasshi. 2022;142(9):965-969. doi: 10.1248/yakushi.22-00089-5.
7
Development and delivery of a pharmacist training program to increase naloxone access in Kentucky.在肯塔基州开展并实施一项药剂师培训计划,以增加纳洛酮的可及性。
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S118-S122. doi: 10.1016/j.japh.2016.12.071. Epub 2017 Feb 1.
8
Addressing the pharmacist shortage through a cooperative internship program for foreign pharmacy graduates.通过针对外国药学专业毕业生的合作实习项目来解决药剂师短缺问题。
J Am Pharm Assoc (2003). 2007 Mar-Apr;47(2):191-6. doi: 10.1331/QJ0N-4278-738U-0061.
9
Continuing pharmacy education practices in geriatric care among pharmacists in the Upper Midwest.美国中西部药师在老年护理方面的持续药学教育实践。
J Am Pharm Assoc (2003). 2019 May-Jun;59(3):361-368. doi: 10.1016/j.japh.2018.12.020. Epub 2019 Feb 14.
10
A scoping review of the methods and processes used by regulatory bodies to determine pharmacists' readiness for practice.监管机构用于确定药剂师是否具备实践能力的方法和流程的范围综述。
Res Social Adm Pharm. 2022 Dec;18(12):4028-4037. doi: 10.1016/j.sapharm.2022.06.010. Epub 2022 Jul 6.

引用本文的文献

1
Impact of State Telehealth Parity Laws for Private Payers on Hypertension Medication Adherence Before and During the COVID-19 Pandemic.私人支付者的州远程医疗均等化法律对高血压药物治疗依从性的影响:在 COVID-19 大流行之前和期间。
Circ Cardiovasc Qual Outcomes. 2024 Aug;17(8):e010739. doi: 10.1161/CIRCOUTCOMES.123.010739. Epub 2024 Jul 29.
2
Implementation of the California advanced practice pharmacist and the continued disappointment of tiered licensure.加利福尼亚高级执业药师的实施以及分级许可制持续令人失望的情况。
Explor Res Clin Soc Pharm. 2023 Oct 20;12:100353. doi: 10.1016/j.rcsop.2023.100353. eCollection 2023 Dec.
3
Federal pharmacist Paxlovid prescribing authority: A model policy or impediment to optimal care?
联邦药剂师开具帕罗韦德(Paxlovid)的处方权:一项模范政策还是优化治疗的障碍?
Explor Res Clin Soc Pharm. 2023 Mar;9:100244. doi: 10.1016/j.rcsop.2023.100244. Epub 2023 Mar 14.